Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Deer antler collagen: a new hope for dry skin and wrinkles?

NCT ID NCT07486414

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a deer antler collagen supplement (NP-2007) in 84 healthy women aged 35-65 with dry skin and eye wrinkles. Over 12 weeks, researchers measured changes in skin moisture, elasticity, and wrinkle depth compared to a placebo. The goal was to see if this supplement can safely improve skin health.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

84 people

The number who actually took part.

Started

Apr 2022

Finished

Sep 2022

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

35 to 65 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Healthy females between 35 and 65 years of age 2. Subjects with dry skin (Skin capacitance ≤ 49 units measured by Corneometer® CM 825) 3. Subjects with eye wrinkles (grade 3 or higher based on visual assessment scale) 4. Subjects who voluntarily signed the informed consent form after receiving a full explanation of the study 5. Subjects who are available for follow-up visits at scheduled times throughout the study period Exclusion Criteria: * 1\) Subjects with skin diseases (atopic dermatitis, psoriasis, etc.) in the test area 2\) Subjects who have used skin-related medications (steroids, etc.) within 1 month 3\) Subjects with a history of hypersensitivity to the test ingredients or severe food allergies 4\) Pregnant or lactating women, or those planning to become pregnant 5\) Subjects who have participated in other clinical trials within the past 3 months 6\) Any other conditions that the investigator deems unsuitable for participation

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Skin aging, dry skin are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Corederm Skin Research Center

    Seoul, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.